Creative Biostructure actively expands business areas in various ways to facilitate long-term sustainable development. We plan to establish new subsidiaries in multiple regions of the world to expand our global business and make active preparations for the large-scale international multi-center pre-clinical/clinical trials in the future.
We believe that great partnerships bring next-level solutions, so we are actively looking for strategic partners. Leveraging our core competency in drug discovery based on structure, we are willing to engage with partners from global academia, biotech/pharmaceutical companies, and clinical research centers, and are open to opportunities for global licensing and co-development. Carrying out strategic cooperation is conducive to giving full play to respective advantages and achieving business synergy.
We support technology transfer organizations (TTO) in their valorization mission and provide solutions facilitating proof-of-concept programs and intellectual property (IP) reinforcement needed for the development of innovations.
Creative Biostructure sincerely welcomes scientists and biotech startups with high-potential drug discovery projects around the world to perform research projects by leveraging our platforms, and a risk-sharing business model may also be applied upon agreement with the partner.